Harris, MD, FCCP discusses Brinsupri™ (brensocatib), a new FDA-approved treatment for non-cystic fibrosis bronchiectasis. Dr ...

Rinatabart sesutecan is an investigational folate receptor alpha-directed, topoisomerase I inhibitor antibody-drug conjugate.

With the best-performing uncertainty metric, 61.9% of examinations were read by radiologists in a recent study.

Child-focused screening for MEB problems should start at age 6 months and continue at 12-, 24-, and 36-month health supervision visits.

Infant RSV immunization coverage through nirsevimab or maternal vaccination ranged from an estimated 11 to 53 percent by state ...

The ATTAIN-2 trial evaluated the efficacy and safety of orforglipron in adults with a BMI of greater than or equal to 27kg/m2 and type 2 diabetes.

When hemoglobin concentration is less than 10g/dL, liberal red blood cell transfusion strategy is suggested.

Significant improvement seen in motor function for patients in combined 20- and 10mg/kg dose groups versus placebo group.

In studies not testing for therapeutic effect, high-concentration THC products had unfavorable links with psychosis, schizophrenia.

Cemdisiran is a subcutaneously-administered, small interfering RNA therapeutic that reduces the production of complement factor 5 in the liver.

HealthDay News — New York City health officials confirmed a sixth death linked to a Legionnaires’ disease outbreak in Harlem where 112 people have now been diagnosed.

Associations seen for vaping and subsequent smoking, substance use, asthma, cough, injuries, and poor mental health.